Patients with T2DM received weekly doses of tirzepatide (1, 5, 10, or 15 mg), dulaglutide (1.5 mg), or placebo for 26 weeks
Given the high potential for automation in centrifugal platforms and the established unit operations on these platforms (e.g., various passive and active valves, serial dilution, washing, cell separation, etc.), this sensing mechanism can be beneficial for future sample-to-answer detection devices, particularly in extreme point-of-care settings and for diagnostics of conditions such as thalassemia, diabetes, and malaria
doi: 10.1007/s13679-025-00611-5
Your weight loss journey starts now
These typically resolve within thirty minutes to a few hours